8-KThe WireStrategic
Security-Holder Rights
Filed Sep 26, 2025 · 9mo ago · Accession 0001493152-25-015725
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗Securities and Exchange Commission on September 23, 2025)
104
Cover Page Interactive Data File, formatted in Inline
XBRL
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
GT BIOPHARMA, INC.
Date: September 26, 2025
By:
/s/ Alan
Urban
Alan Urban
Chief Financial Officer
Filing details
- Company
- GT Biopharma, Inc.
- Ticker
- GTBP
- CIK
- 109657
- Form type
- 8-K
- Filing date
- Sep 26, 2025
- Report date
- Sep 25, 2025
- Document
- form8-k.htm
- Size
- 199 KB